Biotechnology company BioSkryb Genomics and laboratory equipment supplier Tecan Group have collaboratively introduced a single-cell multiomics workflow. The workflow uses BioSkryb’s ResolveOME whole ...

Oestrogen may be a new postnatal therapy to improve lung function and other outcomes in preterm infants, researchers at UT Southwestern Medical Center have found in an animal study. "Ironically, a ...

A decade after the conclusion of a schistosomiasis control program in Mali, prevalence of the disease had regressed to pre-intervention levels, according to a study published May 5 in the open-access ...

Current arthritis medications can ease the pain, but stopping the progression of the disease requires more aggressive treatments: use of very limited available drugs or surgical intervention.

Two things happen following a heart attack-necrosis (normal cell death) and apoptosis (programmed cell death)-and both are bad. Now researchers in Japan have found that a single intravenous dose of ...

We know about good and bad fats. Now suspicion is growing that not all sugars are created equal either. Overweight adults who consume large amounts of fructose have been found to experience alarming ...

French biotechnology and AI specialist company Owkin has launched the K Navigator, an agentic biomedical research co-pilot that can help to accelerate biomedical research. “The ultimate aim for K is ...

CDMO Hovione and biotechnology company Firstgene Life Sciences (of Xlife Sciences) have collaborated to advance Hovione’s drug delivery platform for the targeted treatment of Hepatocellular Carcinoma ...

CRISPR screening is a powerful high-throughput strategy that utilises the programmability and accuracy of CRISPR-Cas systems like CRISPRko, CRISPRa, and CRISPRi to investigate gene function ...

The Pharma AI Council (PAC), an organisation of pharma, biotech and medical device experts, has been launched to shape the innovation and use of generative and agentic AI solutions in these fields.

Biotechnology company Creative Biogene has recently launched a line of gamma-retroviral products capable of efficiently delivering genes into various cell types. Our gamma-retroviral products are ...

Biotechnology company InVitria has launched a chemically defined recombinant IL-2 for immune cell manufacturing called OptiLeukin 2. “With the introduction of OptiLeukin 2, we are providing a clean, ...